Unlock Full History
See how strategy shifts impact long-term alpha.
Fund Overview
About
Investment Strategy
Activity Summary — 2025 Q4
Q4 2025 13F Filed:
Feb 10, 2026
Top Buys
%
$
| Stock | % Impact |
|---|---|
| DHR DANAHER CORPORA.. | +4.33% |
| GOOGL ALPHABET INC.. | +2.94% |
| MSCI MSCI INC.. | +2.57% |
| ADP AUTOMATIC DATA .. | +2.55% |
| TMO THERMO FISHER S.. | +2.46% |
| ISRG INTUITIVE SURGI.. | +2.33% |
Top Sells
%
$
| Stock | % Impact |
|---|---|
| EMR EMERSON ELEC CO.. | -5.42% |
| ZTS ZOETIS INC.. | -3.88% |
| ULTA ULTA BEAUTY INC.. Sold All 😨 Was: 3.92% | -3.75% |
| ORCL ORACLE CORP.. | -2.93% |
| QGEN QIAGEN NV.. | -0.52% |
| ALGN ALIGN TECHNOLOG.. | -0.38% |
Activity Summary
Market Value
$176M
AUM Change
+4.77%
New Positions
1
Increased Positions
24
Closed Positions
5
Top 10 Concentration
+60.89%
Portfolio Turnover
+18.45%
Alt Turnover
+20.73%
Sector Allocation Trends
Free View: Last 10 Quarters. Subscribe to see full
history
Holdings Analysis
Size: % of Portfolio
Color: Last Full-Quarter Return
No data
Free: 10 quarters
Positions Dynamics
Visualizing Top 20 holdings weight history over the last 10 quarters.
Portfolio Analytics — Latest
WORMSER FRERES GESTION risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.
Risk access
Building institutional risk profile...
Guru Intelligence Hub
Pro
Real-time Analytics
High-Conviction Alpha
AAPL
92.4
NVDA
88.1
MSFT
74.3
Strategy Guardian
Style Drift
0.12
Sector Rotation
0.38
Tracking institutional benchmark deviation
Scenario Lab
2008 GFC
-32.4%
Covid-19
-18.1%
2022 Bear
-24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every
holding ·
Strategy Guardian alerts ·
Live Scenario Lab stress tests
Best Strategy vs. Benchmarks
AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for
this
specific strategy.
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
Edge Metrics
Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture
Strategy Backtester: WORMSER FRERES GESTION
Replicate top holdings performance • Compare vs benchmarks • Optimize N
Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.
Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.
⏱ Run Backtest
Liquid Glass Edition
0
Backtests Run
+127%
Avg. Return
👆 Click the button to launch tickers!
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle
behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY
Backtesting WORMSER FRERES GESTION's top 10 holdings against SPY identified 2 underperformance periods. Worst drawdown: 2025-02 – 2025-09 (-23.8% vs SPY, 8 quarters). Currently underperforming.
Avg. lag: -15.7% vs SPY
•
Avg. duration: 6.0 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)
The ticker-level breakdown shows how each of WORMSER FRERES GESTION's top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: EMR (2024 Q4 – 2025 Q2, +3.0 pts), TMO (2024 Q4 – 2025 Q4, +1.3 pts), ECL (2025 Q1 – 2025 Q1, +0.7 pts) .
Strategy ann.: -8.1%
•
SPY ann.: 15.4%
•
Period:
2025–2026
Best Recent Contributors — Last 5Y
All 3 recent top contributors beat SPY,
which means this fund's strongest recent return drivers also outperformed the index over the same window.
2024 Q4 – 2025 Q2
• 3Q in Top 10
Beat SPY
EMR
+35%
SPY
+19%
Contrib
+3.0%
2024 Q4 – 2025 Q4
• 3Q in Top 10
Beat SPY
TMO
+16%
SPY
+10%
Contrib
+1.3%
2025 Q1 – 2025 Q1
• 1Q in Top 10
Beat SPY
ECL
+8%
SPY
+8%
Contrib
+0.7%
■ Stock return (green = beat SPY)
■ Stock return (red = lagged SPY)
■ SPY same period
■ Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy
Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.